Table 1 Baseline characteristics and clinical status on arrival
LMT, n = 39 | pLAD, n = 224 | dLAD, n = 172 | P value | |
|---|---|---|---|---|
Age, year | 71 (62, 77) | 66.5 (56, 75) | 66 (59.3, 75) | 0.1786 |
Male, n | 29 (74.4%) | 182 (81.3%) | 136 (79.1%) | 0.5875 |
Height, cm | 163 (154.7, 169) | 164.4 (158, 170) | 164 (158, 168) | 0.3621 |
Weight, kg | 60 (55, 70) | 65 (55, 72) | 63 (53.8, 72) | 0.3751 |
Current smoking, n | 9 (23.1%) | 80 (35.7%) | 59 (34.3%) | 0.4282 |
Hypertension, n | 35 (89.7%) | 158 (70.5%) | 137 (79.7%) | 0.0115 |
Dyslipidemia, n | 23 (59.0%) | 160 (71.4%) | 128 (74.4%) | 0.1555 |
Diabetes mellitus, n | 16 (41.0%) | 82 (36.6%) | 61 (35.5%) | 0.8088 |
Insulin therapy | 2 (5.1%) | 12 (5.4%) | 9 (5.2%) | 0.9974 |
Hemodialysis, n | 1 (2.6%) | 3 (1.3%) | 3 (1.7%) | 0.8405 |
Hemoglobin, mg/dl | 13.7 (11.2, 15.3) | 14.8 (13.4, 16.1) | 14.4 (13, 15.9) | 0.0134 |
LDL-chol, mg/d | 108.5 (88.3, 133.5) | 123 (101, 150) | 129 (106.8, 155.3) | 0.00171 |
HDL-chol, mg/dl | 45.5 (40, 58.3) | 49 (39, 57) | 47 (39, 58) | 0.9678 |
Triglyceride, mg/dl | 84 (40.8, 110) | 103 (59, 170) | 81 (52.5, 141) | 0.0169 |
Serum creatinine, mg/dl | 1.2 (0.9, 1.5) | 0.9 (0.7, 1.1) | 0.8 (0.7, 1.0) | < 0.0001 |
eGFR, ml/min/1.73 m2 | 46.0 (35.0, 64.3) | 64.7 (51.7, 79.9) | 68.2 (53.7, 82.5) | < 0.0001 |
Shock on arrival, n | 29 (74.4%) | 36 (16.1%) | 17 (9.9%) | < 0.0001 |
Killip I, n | 1 (2.6%) | 89 (39.7%) | 94 (54.7%) | < 0.0001 |
Time of onset to ECG, min | 60.5 (39.8, 230.6) | 78 (45.8, 195.3) | 82 (48.2, 220.0) | 0.1369 |
Peak CPK, IU/l | 11,249 (2961.3, 18,027) | 4059 (2021, 6115) | 2369 (1174.5, 4358.5) | < 0.0001 |
LVEF, % | 35.5 (29.0, 45.0) | 48.5 (41, 54.8) | 51 (44, 58) | < 0.0001 |